Dr. Alireza Maghsoudi, MD

Dr. Maghsoudi practices at Inova Fairfax Hospital - Unit in Falls Church, Virginia.

Dr. Maghsoudi's NPI, 1427024652, was assigned on February 27, 2006. Dr. Maghsoudi graduated from Virginia Commonwealth University, School of Medicine in 1999. Dr. Maghsoudi holds Virginia license 0101233167.

Dr. Maghsoudi's primary practice is Inova Fairfax Hospital - Unit, at 3300 Gallows Rd, Falls Church, VA 22046 in Falls Church City. The practice phone is (703) 698-3659.

Dr. Maghsoudi's primary practice is Inova Fairfax Hospital - Unit in Falls Church, Virginia. Dr. Maghsoudi is also affiliated with Inova Fairfax Hospital. The medical group on file is Inova Urgent Care Center. Dmand AI also links Dr. Maghsoudi to 5 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Maghsoudi practices, 9 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Maghsoudi's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Maghsoudi is licensed in Virginia.

CMS data shows 4,696 Medicare services from Dr. Maghsoudi across 28 procedure codes in 2024, for 2,038 Medicare patients. Medicare paid $921,987 for them.

CMS counts 2,038 Medicare patients who saw Dr. Maghsoudi in 2024. The largest group is 75 to 84, with 855 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Maghsoudi's median patient age at 62, with 46% women.

In 2024, Dr. Maghsoudi wrote 1,821 Medicare Part D claims for 353 patients. 81% of them were for generic drugs. CMS names the drug for 1,664 of them, across 32 drugs with 11 or more claims each, at $505,865 in total drug cost. In 2023, CMS named 1,131 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Maghsoudi for performance year 2024, reported as part of a group. Dr. Maghsoudi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Maghsoudi as offering telehealth.

Dmand AI links 4 papers to Dr. Maghsoudi, published from 2021 to 2023. 2021 was the busiest year, with 2. The most frequent topics are COVID-19, COVID-19 Vaccines and Myocarditis. Dr. Maghsoudi's most frequent co-authors are Hooman Bakhshi, MD, James Andrew De Lemos, MD and Amit Khera, MD, MS.

CMS Open Payments shows 273 general payments to Dr. Maghsoudi from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $918.

Dr. Maghsoudi graduated from Virginia Commonwealth University, School of Medicine in 1999.